User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 15 results.
    • Speech
    Alzheimer's and Parkinson's disease dementia with similar dementia severity compared with the FDG-PET method
    Vander Borght, Thierry[UCL] Minoshima, S. Giordani, B. Berent, S. Kuhl, D.E. (1995) —
    • Speech
    Kinetic evaluation of [C-11]dihydrotetrabenazine (DTBZ) by dynamic PET : a marker for the vesicular monoamine transporter.
    Koeppe, R.A. Frey, K.A. Vander Borght, Thierry[UCL] Kilbourn, M.R. Jewett, D.M. Lee, L.C. Kuhl, D.E. (1995) —
    • Speech
    Stereospecificity of in vitro and in vivo binding of isomers of alpha-[C-11]dihydrotetrabenazine alpha -[C-11]DTBZ) to vesicular monoamine transporters.
    Kilbourn, M.R. Lee, L. Jewett, D.M. Vander Borght, Thierry[UCL] Koeppe, R.A. Frey, K.A. (1995) —
    • Journal article
    Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific.
    Kilbourn, M Lee, L Vander Borght, Thierry[UCL] Jewett, D Frey, K (1995) European journal of pharmacology — Vol. 278, no.3, p. 249-52 (1995)
    • Journal article
    The vesicular monoamine transporter is not regulated by dopaminergic drug treatments.
    Vander Borght, Thierry[UCL] Kilbourn, M Desmond, T Kuhl, D Frey, K (1995) European journal of pharmacology — Vol. 294, no.2-3, p. 577-83 (1995)
    • Journal article
    [3H]methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity.
    Vander Borght, Thierry[UCL] Sima, A A Kilbourn, M R Desmond, T J Kuhl, D E Frey, K A (1995) Neuroscience — Vol. 68, no.3, p. 955-62 (1995)
    • Speech
    The vesicular monoamine transporter is not regulated by dopaminergic drug treatment.
    Vander Borght, Thierry[UCL] Kilbourn, M.R. Desmond, T.J. Kuhl, D.E. Frey, K.A. (1995) —
    • Speech
    Decreased striatal monoaminergic presynaptic terminals in OPCA and MSA demonstrated with [11C]dihydrotetrabenazine and PET.
    Gilman, S. Frey, K.A. Koeppe, R.A. Junck, L. Little, R. Vander Borght, Thierry[UCL] Lohman, M. Martorello, S. Lee, L.C. Jewett, D.M. Kilbourn, M.R. (1995) —
    • Journal article
    In vivo imaging of the brain vesicular monoamine transporter.
    Vander Borght, Thierry[UCL] Kilbourn, M R Koeppe, R A DaSilva, J N Carey, J E Kuhl, D E Frey, K A (1995) Journal of nuclear medicine : official publication, Society of Nuclear Medicine — Vol. 36, no.12, p. 2252-60 (1995)
    • Speech
    In vivo [C-11]dihydrotetrabenazine binding is unaffected by chronic L-DOPA or deprenyl treatment
    Kilbourn, MR Vander Borght, Thierry[UCL] Frey, KA (1995) —
    • Speech
    In vitro and in vivo binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is strereospecific.
    Kilbourn, M.R. Lee, L. Jewett, D.M. Vander Borght, Thierry[UCL] Koeppe, R.A. Frey, K.A. (1995) —
    • Speech
    Kinetic evaluation of [C-11] dihydrotetrabenazine : a PET ligand for assessing the vesicular monoamine transporter.
    Koeppe, R.A. Frey, K.A. Vander Borght, Thierry[UCL] Kilbourn, M.R. Jewett, D.M. Lee, L.C. Kuhl, D.E. (1995) —
    • Speech
    Is regional glucose metabolism different between Alzheimer’s and Parkinson’s disease dementia with similar dementia severity ?
    Vander Borght, Thierry[UCL] Minoshima, S. Giordani, B. Berent, S. Kuhl, D.E. (1995) —
    • Speech
    Reduction of presynaptic monoaminergic vesicles in the striata of parkinsonian patients and in normal human aging.
    Frey, K.A. Koeppe, R.A. Kilbourn, M.R. Vander Borght, Thierry[UCL] Albin, R.L. Gilman, S. Kuhl, D.E. (1995) —
    • Speech
    Interpretation of metabolic abnormalities in Alzheimer's disease using three-dimensional stereotactic surface projections (3D-SSP) and normal database
    Minoshima, S. Frey, K.A. Burdette, J. Vander Borght, Thierry[UCL] Koeppe, R.A. Kuhl, D.E. (1995) —